Cyclosporine/PUVA approach to psoriasis raises cancer risk

Boston - Use of the immunosuppressant cyclosporine on patientswith psoriasis who have had substantial psoralen and ultra violet A lighttreatments show a sevenfold increase in the number of squamous cell cancertumors, according to Robert S. Stern, M.D.

Related Videos
© 2023 MJH Life Sciences

All rights reserved.